This Book is in Good Condition. Clean Copy With Light Amount of Wear. 100% Guaranteed. Summary: List of Contributors.Preface. Foreword. PART I: BASIS OF PHARMACOVIGILANCE. Introduction (R. Mann and E. Andrews). Legal Basis-EU (N. Macfarlane, et al.). Legal Basis-US (R. Brady and M. Learn). Ethical Oversight, Consent and Confidentiality (D. Boswell and E. Andrews). Pre-clinical Safety Evaluation (N. Kellet, S. Mair and W. Nimmo). Metabolic Mechanisms (M. Pirmohamed and B. Park). Drugs and the Elderly (U. Martin and C. George). Natural History (P. Stang). Responding to Signals (P. Waller and P. Arlett). Micturin and Torsades de Pointes (R. Wild). Withdrawal of Terodiline: A Tale of Two Toxicities (R. Shah). Nomifensine and Haemolytic Anaemia (P. Stonier and J. Edwards). PART II: SIGNAL GENERATION. WHO Programme-Global Monitoring (I. Edwards and S. Olsson). Regulatory Pharmacovigilance in the EU (P. Waller and P. Bahri). Spontaneous Reporting-UK (S. Davis and J. Raine). Spontaneous Reporting-France (N. Moore, C. Kreft-Jais and A. Dahnani). Spontaneous Reporting-USA (D. Graham, S. Ahmad and T. Piazz-Hepp). Algorithms (J. Clark). Overview-Spontaneous Signalling (J. Clark, S. Klincewicz and P. Stang). Statistical Methods of Signal Detection (S. Evans). Statistical Methods of Evaluating Pharmacovigilance Data (B. Bgaud). Data Mining (I. Edwards et al.). Epidemiology of Adverse Events Associated with Epilepsy and Use of Lamotrigine (P. Tennis). Pharmacovigilance in the Netherlands (A. van Grootheest and E. van Puijenbroek). CIOMS Working Groups and their Contribution to Pharmacovigilance (S. Roden). PEM in the UK (S. Shakir). PEM in New Zealand (D. Coulter). MEMO in the UK (D. Steinke, J. Evan and T. Macdonald). GPRD in the UK (L. Wood). Overview of North American Databases (B. Storm and J. Kinman). Pharmacovigilance in the HMO Research Network (R. Platt et al.). Other Databases in Europe (M. Sturkenboom). Surveillance for Medical Devices-USA (T. Gross and L. Kessler). PART III: PHARMACOVIGILANCE AND SELECTED SYSTEM ORGAN CLASSES. Dermatological ADRs (L. Valeyrie and J.-C. Roujeau). Gastrointestinal ADRs (J. Wood and G. Pipkin). Haematological ADRs (S. Davis and R. Mann). Hepatic Adverse Drug Reactions (G. Aithal and C. Day). Ocular ADRs (F.W. Fraunfelder and F.T. Fraunfelder). Drug Safety in Pregnancy (C. Chambers and E. Andrews). ADRs and Drug Safety 1999-2000 (P. Curel and R. Stather). PART IV: LESSONS AND DIRECTIONS. Teaching Pharmacovigilance (R. Meyboom, S. Olsson and M. Thorogood). Medical Errors and Lessons from Drug-Related Deaths (R. Ferner and R. Whittington). Pharmacogenetics and the Genetic Basis of ADRs (P. Manasco et al.). Keynote Clinical Lessons from Pharmacovigilance (D. Lawson). Index. Buchnummer des Verkäufers
Inhaltsangabe: Interest in the field of pharmacovigilance has grown rapidly in recent years with the possible toxicity of a drug becoming as much a focus of clinical trials as its benefits. This key text is a definitive resource for professionals working within pharmacovigilance. Written by leading professionals in the field, its clear structure, covers all the important aspects of the subject including:-
* Legal aspects
* Drug regulatory requirements
* Methods of signal generation
* Reporting schemes
* Pharmacovigilance in selected system-organ classes
* Future directions
This comprehensive book should be in all pharmacovigilance departments, regional
pharmacovigilance centres and regulatory authorities. It is an unparalleled
source of information and reference for all researchers in pharmacovigilance, pharmaceutical practice and medicine.
This key text is a one-stop source of pharmacovigilance. Its clear sructure, with six main parts, covers all the important aspects of the subject including legal aspects, drug regulatory requirements, methods of signal generation, reporting schemes and pharmacovigilance in selected system-organ classes. The book then goes on to look at possible future directions.
* the editors are of excellent standing within the pharmacovigilance community and have chosen the chapter authors with care
* the text provides exemplary coverage of all the relevant issues
* is the definitive book on the subject
The book should be in all pharmacovigilance departments, regional pharmacovigilance centres and regulatory authorities. It is an unparalleled source of information and reference for all researchers in pharmacovigilance, pharmaceutical practice and medicine.
Buchbeschreibung Wiley, 2002. Buchzustand: Good. 1st Edition. N/A. Ships from the UK. Former Library book. Shows some signs of wear, and may have some markings on the inside. Buchnummer des Verkäufers GRP91157459
Buchbeschreibung . Hardback. Buchzustand: Very Good. The book has been read, but is in excellent condition. Pages are intact and not marred by notes or highlighting. The spine remains undamaged. Buchnummer des Verkäufers GOR007787108
Buchbeschreibung Wiley, 2002. Hardcover. Buchzustand: Good. Satisfaction 100% guaranteed. Buchnummer des Verkäufers mon0001136283
Buchbeschreibung Wiley-Blackwell, 2002. Buchzustand: Fair. This is an ex-library book and may have the usual library/used-book markings inside.This book has hardback covers. In fair condition, suitable as a study copy. No dust jacket. , 1450grams, ISBN:9780471494416. Buchnummer des Verkäufers 6836066
Buchbeschreibung Wiley 2002-06-15, 2002. Hardcover. Buchzustand: good. 1st. 0471494410. Buchnummer des Verkäufers 505165
Buchbeschreibung Wiley, 2002. Hardcover. Buchzustand: Used: Good. Buchnummer des Verkäufers 13907752
Buchbeschreibung Wiley, 2002. Hardcover. Buchzustand: Good. Good condition, some are ex-library and can have markings. Buchnummer des Verkäufers GD-026-01-9057409
Buchbeschreibung Wiley, 2002. Hardcover. Buchzustand: New. 1. Buchnummer des Verkäufers DADAX0471494410